JP2005513422A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005513422A5 JP2005513422A5 JP2003546738A JP2003546738A JP2005513422A5 JP 2005513422 A5 JP2005513422 A5 JP 2005513422A5 JP 2003546738 A JP2003546738 A JP 2003546738A JP 2003546738 A JP2003546738 A JP 2003546738A JP 2005513422 A5 JP2005513422 A5 JP 2005513422A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- nucleic acid
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 51
- 108090000765 processed proteins & peptides Proteins 0.000 claims 51
- 229920001184 polypeptide Polymers 0.000 claims 50
- 150000001875 compounds Chemical class 0.000 claims 30
- 239000002773 nucleotide Substances 0.000 claims 23
- 125000003729 nucleotide group Chemical group 0.000 claims 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims 22
- 102000039446 nucleic acids Human genes 0.000 claims 21
- 108020004707 nucleic acids Proteins 0.000 claims 21
- 150000007523 nucleic acids Chemical class 0.000 claims 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 20
- 230000000694 effects Effects 0.000 claims 16
- 238000000034 method Methods 0.000 claims 16
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims 12
- 102000015439 Phospholipases Human genes 0.000 claims 12
- 108010064785 Phospholipases Proteins 0.000 claims 12
- 230000033115 angiogenesis Effects 0.000 claims 9
- 230000002491 angiogenic effect Effects 0.000 claims 9
- 230000002062 proliferating effect Effects 0.000 claims 9
- 208000035269 cancer or benign tumor Diseases 0.000 claims 5
- 230000004663 cell proliferation Effects 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 3
- 208000026310 Breast neoplasm Diseases 0.000 claims 3
- 206010009944 Colon cancer Diseases 0.000 claims 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 3
- 206010033128 Ovarian cancer Diseases 0.000 claims 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 3
- 208000029742 colonic neoplasm Diseases 0.000 claims 3
- 201000005202 lung cancer Diseases 0.000 claims 3
- 208000020816 lung neoplasm Diseases 0.000 claims 3
- 230000003321 amplification Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33346201P | 2001-11-27 | 2001-11-27 | |
| US33442301P | 2001-11-30 | 2001-11-30 | |
| US39134102P | 2002-06-25 | 2002-06-25 | |
| PCT/US2002/038348 WO2003045229A2 (en) | 2001-11-27 | 2002-11-26 | Methods and compositions for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005513422A JP2005513422A (ja) | 2005-05-12 |
| JP2005513422A5 true JP2005513422A5 (enExample) | 2006-01-19 |
Family
ID=27406920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546738A Pending JP2005513422A (ja) | 2001-11-27 | 2002-11-26 | 癌を処置するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20030153018A1 (enExample) |
| EP (1) | EP1448790A4 (enExample) |
| JP (1) | JP2005513422A (enExample) |
| AU (1) | AU2002360454A1 (enExample) |
| WO (1) | WO2003045229A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1431399A1 (en) * | 2002-12-20 | 2004-06-23 | Clinigenetics | Methods and composition for identifying therapeutic agents of atherosclerotic plaque lesions |
| WO2012135714A2 (en) * | 2011-03-30 | 2012-10-04 | Whitehead Institute For Biomedical Research | Serine biosynthesis pathway inhibition for treatment of cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1466401A (en) * | 1999-11-04 | 2001-05-14 | Incyte Genomics, Inc. | Human transferase molecules |
| US6569662B1 (en) * | 2000-01-21 | 2003-05-27 | Hyseq, Inc. | Nucleic acids and polypeptides |
| JP2005522999A (ja) * | 2002-01-31 | 2005-08-04 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 癌を処置するための方法および組成物 |
| AU2003297318A1 (en) * | 2002-12-20 | 2004-07-22 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
-
2002
- 2002-11-25 US US10/303,664 patent/US20030153018A1/en not_active Abandoned
- 2002-11-26 EP EP02795711A patent/EP1448790A4/en not_active Withdrawn
- 2002-11-26 WO PCT/US2002/038348 patent/WO2003045229A2/en not_active Ceased
- 2002-11-26 JP JP2003546738A patent/JP2005513422A/ja active Pending
- 2002-11-26 AU AU2002360454A patent/AU2002360454A1/en not_active Abandoned
-
2006
- 2006-12-05 US US11/633,986 patent/US20070087375A1/en not_active Abandoned